Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
GlaxoSmithKline
GlaxoSmithKline
Page 4 of 5
Health
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
By
Tech Reporter
March 30, 2017
Health
Why GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead
By
Contributing Writer
December 21, 2016
Finance
The 4 Best Brexit-Proof Foreign Stocks to Buy for 2017
By
Investment Desk
December 1, 2016
Health
GSK’s CEO Explains How Big Pharma Can Help the Poor and Still Make Money
By
Editorial Team
November 3, 2016
Health
Here’s What We Could Be Doing to Stop Pandemics Like Zika and Ebola
By
Blockchain Reporter
November 2, 2016
Health
Why Doctors Without Borders Is Rejecting 1 Million Free Vaccines From Pfizer
By
Tech Reporter
October 12, 2016
Commentary
Why the Market Punishes Some Companies With Female CEOs
By
Staff Writer
September 28, 2016
Leadership
GlaxoSmithKline Just Named This Woman Its New CEO
By
Investment Desk
September 20, 2016
Health
GlaxoSmithKline Cuts Vaccine Cost for Refugees
By
Research Team
September 19, 2016
Health
How GlaxoSmithKline Is Changing the World
By
Financial Writer
August 18, 2016
Leadership
How Coins2Day’s ‘Change the World’ Companies Profit From Doing Good
By
Blockchain Reporter
August 18, 2016
Health
New Incentives Needed to Develop Antibiotics to Fight Superbugs
By
News Correspondent
May 29, 2016
Health
GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By
Industry Analyst
April 4, 2016
Health
GlaxoSmithKline Is Expanding Drug Access to the World’s Poorest Countries
By
Market Analyst
March 31, 2016
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By
Investment Desk
March 31, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer
Economy
The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
By
Financial Writer
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Tech Reporter